Dapiprazole
From Wikipedia, the free encyclopedia
Not to be confused with Aripiprazole.
 |
|
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a601043 |
| Pregnancy category |
|
| Routes of administration |
Topical (eye drops) |
| ATC code | S01EX02 (WHO) |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | Negligible when administered topically |
| Identifiers | |
|
|
| CAS Number | 72822-12-9  |
| PubChem (CID) | 3033538 |
| IUPHAR/BPS | 7155 |
| DrugBank | DB00298 |
| ChemSpider | 2298190 |
| UNII | 5RNZ8GJO7K |
| KEGG | D07775 |
| ChEBI | CHEBI:51066 |
| ChEMBL | CHEMBL1201216  |
| Chemical and physical data | |
| Formula | C19H27N5 |
| Molar mass | 325.451 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (what is this?) (verify) |
|
Dapiprazole (Rev-Eyes) is an alpha blocker. It is used to reverse mydriasis after eye examination.[1]
References[edit]
- ^ Doughty, Michael J.; Lyle, William M. (May 1992). "A Review of the Clinical Pharmacokinetics of Pilocarpine, Moxisylyte (Thymoxamine), and Dapiprazole in the Reversal of Diagnostic Pupillary Dilation". Optometry & Vision Science. 69 (5).
 |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
